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The thymus is essential for a functional immune system, because
the thymic stroma uniquely supports T lymphocyte development.
We have previously identified the epithelial progenitor population
from which the thymus arises and demonstrated its ability to
generate an organized functional thymus upon transplantation.
These thymic epithelial progenitor cells (TEPC) are defined by
surface determinants recognized by the mAbs MTS20 and MTS24,
which were also recently shown to identify keratinocyte progen-
itor cells in the skin. However, the biochemical nature of the MTS20
and MTS24 determinants has remained unknown. Here we show,
via expression profiling of fetal mouse TEPC and their differenti-
ated progeny and subsequent analyses, that both MTS20 and
MTS24 specifically bind an orphan protein of unknown function,
Placenta-expressed transcript (Plet)-1. In the postgastrulation em-
bryo, Plet-1 expression is highly restricted to the developing
pharyngeal endoderm and mesonephros until day 11.5 of embry-
ogenesis, consistent with the MTS20 and MTS24 staining pattern;
both MTS20 and MTS24 specifically bind cell lines transfected with
Plet-1; and antibodies to Plet-1 recapitulate MTS20/24 staining. In
adult tissues, we demonstrate expression in a number of sites,
including mammary and prostate epithelia and in the pancreas,
where Plet-1 is specifically expressed by the major duct epithelium,
providing a specific cell surface marker for this putative reservoir
of pancreatic progenitor/stem cells. Plet-1 will thus provide an
invaluable tool for genetic analysis of the lineage relationships and
molecular mechanisms operating in the development, homeosta-
sis, and injury in several organ/tissue systems.
thymus development  MTS24  endoderm  mesonephros
The thymus is the central site of T cell generation (1) andtherefore is critical for adaptive immunity. The cellularity of the
thymus is complex. However, its specialist functions reside largely
in the diverse array of thymic epithelial cell (TEC) types that form
a key component of the thymic stroma (2–4). Previous work from
this and other laboratories has identified and characterized a
population of epithelial progenitor cells within the mouse thymic
primordium that is sufficient to generate an organized functional
thymus containing all TEC subtypes upon ectopic transplantation
(5–7). This population is identified bymAbsMTS20 andMTS24 (5,
8). That it contains a common TEPC was initially suggested by the
demonstration that the thymus arises solely from the endoderm (9,
10) and was recently confirmed by clonal analysis (11, 12). In the
postnatal mouse thymus, MTS20 and MTS24 identify a rare
subpopulation of cytokeratin 5 cells located in the thymic medulla
and at the corticomedullary junction (6–8), prompting speculation
that these may be resident stem/progenitor cells. Consistent with
this idea, increased numbers of postnatal MTS24 cells have been
reported after induction of thymus regeneration by systemic kera-
tinocyte growth factor (KGF) treatment (13). Recently,MTS24 has
also been shown to identify a novel population of putative kera-
tinocyte progenitor/stem cells in the mouse hair follicle (14) that is
distinct from the classic follicular stem cell population located in the
bulge region (15).
In addition to its utility as a biomarker for TEPC and keratin-
ocyte progenitors, a role for theMTS24 antigen in thymopoiesis has
been indicated by function-blocking experiments, inwhich inclusion
of MTS24 completely abrogated T cell development (7). However,
despite intensive investigation, themolecular identity of theMTS20
and MTS24 antigens has remained elusive, severely hampering
further analysis both of the function of these antigens and of the
function, lineage relationships, and requirements of MTS20 and
MTS24 cells.
Results
Global Expression Profiling of Mouse TEPC and Their Progeny. To
identify markers of TEPC, an in silico subtractive strategy was
devised based on analysis of global gene expression patterns in
TEPC and their presumptive differentiated progeny isolated at day
15.5 of mouse embryonic development (E15.5); a further aim was
to identify the genes encoding the MTS20 and MTS24 antigens.
Thus, MTS20 TEPC and the corresponding MTS20 epithelial-
enriched cell population were obtained from microdissected E15.5
mouse thymic primordia by flow cytometric cell sorting. RNA from
1  106 cells pooled from each population was processed for
hybridization to AffymetrixMOE430 A and B arrays. The resulting
datasets were normalized by usingRMAanalysis (16) implemented
in GENESPRINGGX software (Agilent), and assessment of these
data using a variety of parameters indicated their high quality. In a
pilot analysis designed to investigate the feasibility of identifying
TEPC markers using this approach, data from a single E15.5
dataset were filtered using GENESPRING for elements more
highly expressed in theMTS20 than theMTS20 populations and
were then selected and ranked by fold change to obtain a list
obeying the criteria of: 2-fold increase in MTS20 vs. MTS20
datasets and fluorescence intensity 100. This list was further
filtered using the GO terms ‘‘integral to membrane,’’ ‘‘intrinsic to
membrane’’ and ‘‘anchored to membrane,’’ and Affymetrix anno-
tation for predicted transmembrane domains (based on the pre-
diction programTMHMM).This analysis was followedby statistical
analysis in Limma (http://www.bioconductor.org) (17, 18), after
inclusion of two additional E15.5 datasets. P values were adjusted
by using the Benjamini and Hochberg False Discovery rate (19).
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Genes on the initial list whose subcellular localization was not
identified via annotation were then analyzed for the presence of
putative transmembrane domains bymanual curation. A list of nine
candidates remained after these filtering steps: RIKEN cDNA
1600029D21 gene (1600029D21Rik; Plet-1); Claudin 4 (Cldn4);
Claudin 7 (Cldn7); v-erb-b2 erythroblastic leukemia viral oncogene
homolog 3 (Erbb3); suppression of tumorigenicity 14 (St14); ATPase,
Ca2 transporting, ubiquitous (Atp2a3); frizzled homolog 3 (Fzd3);
ATPase, Na/K transporting beta 1 polypeptide (Atp1b); and occlu-
din (Ocln) [as annotated from the Affymetrix identifiers in
NETAFFX, www.affymetrix.com; supporting information (SI) Ta-
ble 2]. Subsequent qRT-PCR analysis of E15.5 MTS20 vs.
MTS20 epithelium-enriched TECs validated the differential ex-
pression of all candidates tested (Table 1). However, a fold change
of 2 was indicated for four genes, Ocln, Erbb3, Atp1b1, and St14,
and these were excluded from subsequent analysis.
Identification of the MTS20 and MTS24 Antigen. To determine
whether the gene(s) encoding the MTS20 or MTS24 antigens were
among the remaining candidates, we next analyzed their expression
by immunohistochemical and/or qRT-PCR analysis of MTS20
epithelial cells andMTS20 epithelial-enriched cells obtained from
E12.5 thymus primordia and postnatal thymi, focusing initially on
the three top-ranked candidates. These analyses excluded Cldn4
and Cldn7 as either the MTS20 or MTS24 antigen, because
although these proteins were broadly coexpressed withMTS20 and
MTS24 at E12.5–E15.5 (SI Fig. 7) in postnatal thymi,MTS24 cells
formed only a minor subset of Cldn4 and Cldn7 cells (Fig. 1).
Plet-1, however, was highly up-regulated in both E15.5 and post-
natal MTS20 TEPC relative to MTS20CD45 stromal cells
(Table 1), suggesting it as a strong candidate.
Plet-1 was previously identified via an EST screen for placental
expressed transcripts, but neither its full developmental expression
pattern nor function have been described (20). The expression
pattern reported from E5.5 to E8.0 establishes that Plet-1 is
expressed in the ectoplacental cone and extraembryonic ectoderm
(E5.5–E8.0) and additionally in the ventral node at E7.5 and E8
(21). Therefore, to determine whether the spatial and temporal
expression pattern of Plet-1 from gastrulation to midgestation in
mouse was consistent with that of theMTS20 andMTS24 antigens,
in situ hybridization (ISH) was carried out on whole embryos from
E8.5 to E12.5. During this period, detectable Plet-1 expression
appeared restricted to the pharyngeal endoderm and mesonephros
regions (Fig. 2 A–H). In addition, weak staining was sometimes
apparent in the ectoderm of the pharyngeal clefts. In the pharyn-
geal endoderm, expression was observed throughout the foregut at
E8.5 and was then progressively restricted to the pharyngeal
pouches.
These data are highly consistent with those obtained by immu-
nohistochemical staining with MTS20 and MTS24, which E9.5 and
E10.5 revealed strong expression throughout the pharyngeal
endoderm and pouches (Fig. 2 I and J), consistent with reported
E10.5 staining (7), and in an interlimb stripe that is likely the
mesonephros component of the aorta-gonad-mesonephros region
in which definitive hematopoietic stem cells arise during fetal
development (22). Occasional weaker staining was also seen in the
surface ectoderm of the buccal cavity and pharyngeal arches and in
mesodermal cells adjacent to the pharyngeal pouches (data not
shown).
To further investigate the relationship between Plet-1 expression
and MTS20 and MTS24 staining, qRT-PCR analysis was per-
formed on purified MTS20 and MTS20 TECs. This revealed
dynamic expression of Plet-1 within the developing thymus primor-
dium; high relative expression levels were observed at E11.5 and
thereafter, the level of Plet-1 decreased markedly until E14.5 (Fig.
3), corresponding to the observed drop in mean fluorescence
detected on the surface of most MTS20 cells by flow cytometry at
these time points (6, 7). By E15.5, strong expression was again
evident, suggesting either maintenance of high-level expression in
a minor population of cells that is purified selectively at E15.5 or
reinitiation of high-level expression at this time point (SI Fig. 8).
These analyses were again consistent with both flow cytometric and
Table 1. Relative expression levels of candidates as determined
by qRT-PCR
Common name
Relative expression in MTS20/relative
expression in MTS20
E15.5 Postnatal TEC
1600029D21Rik 18  4.5 11,300  1,625*
Cldn4 3.5  0.6 ND
Cldn7 7.8  1.4 ND
Erbb3 1.5  0.4 ND
St14 1.5  0.1 ND
Atp2a3 ND ND
Fzd3 ND ND
Atp1b1 1.7  0.1 ND
Ocln 2.1  0.2 ND
The MTS20CD45Ter119 and MTS20CD45-Ter119 populations from
E15.5 fetal thymi and epithelial enriched MTS20CD45CD11b fraction from
postnatal thymi were isolated and analyzed by real-time PCR with primers
specific for the genes listed. Data were normalized by using the geometric
mean of three housekeeper genes (Hprt,Hmbs, andYwhaz) and are presented
as fold change of MTS20 vs. MTS20 cells (SD) at each time point. Data
shown are representative of two technical replicates.
*Postnatal MTS20 cells were compared to E13.5 MTS20CD45 TEC.
Fig. 1. Expression analysis of candidates excludes
Cldn4 and Cldn7. Immunohistochemical analysis show-
ing MTS24 (blue) and (A) -Cldn4 or (B) -Cldn7 (red)
staining in the postnatal mouse thymus. Images show
sections of postnatal thymus tissue, with Cldn expres-
sion restricted to the medulla as previously described
(29). The far right in A and B shows representative
high-power images. Most if not all MTS24 cells ex-
press Cldn4 and Cldn7 but are a subset of Cldn4 and
Cldn7 cells.
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immunohistochemical analyses usingMTS20 andMTS24 (SI Fig. 8
and refs. 6 and 7).
The full-length Plet-1 cDNA was therefore cloned from mouse
fetal thymus and transiently expressed inCOS-7 cells; the full length
Cldn7 cDNA was also cloned and used as a control in subsequent
analyses. Plet-1- but not Cldn7-transfected COS-7 cells specifically
bound both MTS20 and MTS24 at levels consistent with transfec-
tion efficiency (shown forMTS20 in SI Fig. 9), suggesting that Plet-1
was the antigen recognized by both MTS20 and MTS24. Stably
transfected Plet-1-COS-7 cell lines were subsequently generated
and analyzed, confirming this binding specificity (Fig. 4 A and B).
Plet-1 has a predicted molecular mass of 23.2 kDa and, in keeping
with this, probing ofWestern blots of membrane preparations from
fetal thymic tissue with MTS20 revealed a band of 23 kDa (Fig.
4C). Several higher-molecular-mass bands were also observed,
consistent with the presence of predicted glycosylation sites in
Plet-1 (see below). A rat mAb, 1D4, was subsequently raised to
Plet-1 by immunization of rats with the Plet-1-COS-7 cells. This
mAb revealed a band of the same molecular weight as MTS20 by
Western blotting (Fig. 4C) and completely colocalized with both
MTS20 and MTS24 in the fetal and postnatal thymus by flow
cytometric and immunohistochemical analysis (Fig. 4 D–F). Col-
lectively, these data establish that Plet-1 is the cognate antigen for
both MTS20 and MTS24.
Plet-1 Is an Orphan Protein of Unknown Function. To seek informa-
tion regarding the likely function of Plet-1, we conducted extensive
bioinformatic analyses. Database searches identified Plet-1 related
sequences only in avian and mammalian species (SI Fig. 10) and
revealed the existence of two splice variants in the mouse, with
alternate exons 4. RT-PCR analysis indicated that ‘‘mouse1’’ is the
major and probably only form expressed in the fetal mouse thymus
(not shown), and this is also the predominant variant present in the
National Center for Biotechnology Information EST database.
Further analysis using SignalP and Phobius predicted an amino
terminal signal sequence in all Plet sequences (SI Fig. 10). Plet-1 is
annotated as having aC-terminal transmembrane (TM) region, and
this region is predicted for the mouse1, rat, and hamster sequences
using TMHMM. In addition, a GPI anchor was predicted by two
independent prediction algorithms in mouse1, rat, and hamster,
consistent with reports that the hamster orthologue of Plet-1 is GPI
anchored (23). Notably, ‘‘mouse2’’ lacks both the GPI anchor and
TM sites (SI Fig. 10), suggesting the existence of a secreted isoform.
Other than these features and a number of potential glycosylation
sites, we found no known functional motifs in the Plet-1 coding
sequence of any species. Although ProSite identified a region of
homology with Threonine-rich region/Ig and major histocompati-
bility complex domain/Type I antifreeze protein containing protein,
this was not considered significant because of the high likelihood of
this pattern arising by chance.
As described, Plet-1 is poorly conserved between species (20);
only 34% identity exists between mouse Plet-1 and the human
orthologue predicted by sequence.NeitherMTS20norMTS24 bind
fetal or postnatal human thymus tissue (data not shown). Although
this could be explained by a lack of conserved epitopes, a recent
Fig. 2. Expression profile of Plet-1 during mouse embryonic development.
(A–H) ISH of whole embryos showing specific expression of Plet-1 in prepouch
pharyngeal endoderm at E8.5 (A and B) and in the pharyngeal pouches and
mesonephros from E9.5 to E11.5 (C–H). (Iand J) Immunohistochemical staining
with MTS24 and -pancytokeratin (panK) in the pharyngeal region of a
representative E9.5 embryo. B shows detail from A and D, detail from C. (H)
shows internal view of hemisected E11.5 embryo. I and J are serial sections and
are representative of the staining seen in at least three separate experiments.
en, endoderm; ec, ectoderm; LB, fore limb bud; PP, pharyngeal pouch; pc,
pharyngeal cleft; T, tail. Arrows in A and B indicate pharyngeal endoderm.
Arrow in E indicates mesonephros region. Arrowheads in F–H show third
pharyngeal pouch. Arrowhead in I indicates oral epithelium in the buccal
cavity. Arrowheads in J indicate pharyngeal pouches 1–3 (left to right,
respectively).
Fig. 3. Dynamic regulation of Plet-1 during thymus organogenesis. Plot
shows qRT-PCR analysis of Plet-1 expression in MTS20CD31CD45
Ter119PDGFR and MTS20CD31CD45Ter119PDGFR cells isolated at
different stages of thymus organogenesis. Plet-1 levels are expressed relative
to HPRT. Data shown are representative of more than three biological
replicates.
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report has indicated suboptimal splice donor and acceptor sites at
exons 2 and 3 of human Plet-1, rendering expression of its mRNA
highly inefficient (20). Consistent with this, analysis of microarray
datasets available in the public domain revealed no evidence of
human Plet-1 expression. Therefore, to determine whether Plet-1
was expressed during human thymus development, day 54 to day 70
human fetal thymus tissue was obtained with full ethical approval
and consent, and used to generate cDNA. Thymus development at
these stages is equivalent to that at E9.5–E11.5 in the mouse, based
on phenotypic and morphological analyses (A.M.F., L. Morris, and
C.C.B., unpublished work). Extensive RT-PCR analysis of this
cDNA using primers against human Plet-1 failed to reveal expres-
sion of this gene (Fig. 5A), although other thymus-specific tran-
scripts including Foxn1 were readily detected (Fig. 5A), and the
huPlet-1-specific primers amplified the appropriate fragments from
human genomic DNA (Fig. 5B).
Plet-1 Is a Marker of Pancreatic Duct Epithelium. It was previously
suggested that MTS24 might mark a common endodermal progen-
itor cell early inmouse development (7). Therefore, we investigated
the distribution of this protein in endodermal organ primordia in
further detail, focusing on the pancreas because of the importance
of identifying cell types that can generate pancreatic beta cells.
Consistent with the ISH analysis, no staining was detected at E9.5
or E10.5 in the midgut endoderm caudal to the pharyngeal region.
This, together with the expression pattern reported in earlier
development (21), indicates that Plet-1 is unlikely to mark a
common endodermal progenitor. However, MTS24 staining was
detected at E11.5 and from E13.5 to E15.5 in a small group of cells
in the epithelial region of the pancreas (SI Fig. 11A) and was also
observed in the fetal liver (not shown). In adult tissues, MTS24 has
been reported to identify a novel population of keratinocyte
progenitor/stem cells (14) and is known to bind several other tissues
(6, 7). To determine whether it may be a generic marker of
epithelial stem/progenitor cells, we surveyed MTS24/Plet-1 expres-
sion in selected additional postnatal tissues. MTS24 bound epithe-
lial cells in mammary (Fig. 6A, SI Fig. 11B) and prostate tissue (not
shown), although localization was not restricted to recently de-
scribed epithelial stem/progenitor pools in either tissue (24–26). In
kidney, it colocalized with Cldn4 in medullary collecting ducts (Fig.
6B) (27). In the small intestine, MTS24 identified CD45 cells
within Peyer’s and Crypto patches but did not bind any cells in the
intestinal crypts (Fig. 6C). Staining of adult pancreas however
revealed MTS24 binding to the epithelium of the major ducts,
confirmed by colocalization with the duct-specific markers anti-pan
cytokeratin (Fig. 6D) and DBA lectin (not shown). MTS24 there-
fore provides a specific cell surface marker for this cell type, which
is strongly implicated as the source of facultative islet stem/
progenitor cells induced in some pancreatic injury models (28, 29).
Discussion
The data presented identify Plet-1 as the cognate antigen for mAbs
MTS20 and MTS24, which have previously been shown to identify
Fig. 4. Identification of Plet-1 as the MTS20 and
MTS24 antigen. (A and B) Flow cytometric analysis
showing specific binding of MTS20 and MTS24 to COS
cells transfected stably with Plet-1 (A) but not to un-
transfected COS cells (B) (blue lines). Isotype controls
are shown in red. (C) Western blots of membrane
fractions obtained from E12.5 thymic tissue were
probed with MTS20, 1D4, or appropriate isotype con-
trols. A specific band of 23 kDa is revealed by both
mAbs (arrow). (D) 1D4 binds stable Plet-1-CHO cell
transfectants (green line) but does not bind the paren-
tal CHO line (red line). Blue line shows isotype control
on Plet-1-CHO transfectants. (E) Flow cytometric anal-
ysis of the E12.5 thymus primordium showing com-
plete colocalization of 1D4 and MTS20. (F) Immunohis-
tochemical analysis of postnatal mouse thymus tissue
showing complete co-localization of 1D4 (green) and
MTS20 (red). Nuclear counterstain is DAPI (blue).
Fig. 5. Plet-1 is not expressed in human thymus development. (A) RT-PCR
analysis of day 60 human fetal thymus shows no evidence of Plet-1 expression.
Images show results of amplification with primer pairs predicted to amplify
products from exons (ex) 1–2, 2–3, and 3–4 of Plet-1 and using Foxn1- and
GAPDH- specific primers. The predicted bands were amplified for both Foxn1
and GAPDH. H, no template (water) control;  and , plus or minus reverse
transcriptase. (B) PCR analysis of genomic DNA validates the Plet-1-specific
primers used in A. Image shows the predicted bands of 4.9 kb for exon1F and
exon2R (lane 1), 2.9 kb for exon2F and exon3R (lane 2), and 3.3 kb for exon3F
and exon4R (lane 3), specifically amplified from genomic DNA. Markers (far
left lane) are 1-kb ladder.
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progenitor cell populations in the fetal thymus and postnatal skin
in themouse (6, 7, 14). This finding unifies those of Nijhof et al. (14)
and Tatefuji et al. (23), who independently identified MTS24 and
Plet-1 populations in mouse and hamster skin. In addition, they
indicate MTS24/Plet-1 as a novel marker of pancreatic major duct
epithelium, providing the first specific cell surface marker for this
putative reservoir of pancreatic stem cells (28, 29), and demonstrate
MTS24/Plet-1 expression inmammary andprostate epithelial tissue
and in Peyer’s and Crypto patches.
This study also identified the tight junction proteins Cldn4 and
Cldn7 as candidatemarkers of TEPC.Expression ofCldn4 has been
reported in the fetal and adult mouse thymus (30), whereas Cldn7
has been reported only as a marker of terminally differentiated
TECs (31), and our data therefore extend these findings. Although
Cldn4 and -7 exhibit a high degree of colocalization with MTS24 at
early developmental stages, in the postnatal thymus, MTS24 cells
are aminor subset ofCldn4 andCldn7 cells, suggesting a possible
precursor:progeny relationship between the MTS24 cells and the
broader population(s) defined byClaudin expression. These lineage
relationships are of particular interest, because Cldn3 and –4, in
conjunctionwithUlex europaeus lectin (UEA-1), have recently been
shown to mark precursors for the subset of medullary TEC that
expressAutoimmune regulator (AIRE1) (30), a gene that is critically
required for induction of self tolerance in the maturing T cell pool.
Collectively, the reported findings will facilitate prospective
isolation and functional testing of several medically important cell
populations. Furthermore, they enable genetic analysis of the
function, lineage potential, and molecular requirements of popu-
lations defined on the basis of MTS20 or MTS24 binding during
organ/tissue development, homeostasis, and regeneration. We en-
visage that this advance will contribute important information to
understanding of thymus, skin, and pancreas biology and of the
fetal hematopoietic stem cell niche, in particular, by permitting
definitive evaluation of the role of MTS24 cells in the fetal and
postnatal thymus, and of the capacity of pancreatic ductal epithe-
lium to regenerate  cell mass.
Materials and Methods
Mice.CBAxC57BL/6 F1 mice were used for all analyses. For timed matings, C57BL/6
femaleswerematedwithCBAmales,andnoonof thedayof thevaginalplugwas
taken as E0.5.
Embryo Dissection. Embryos were dissected from the uterus in either PBS or M2
medium (Sigma), then processed for ISH or placed in TRIzol (Invitrogen) for RNA
extraction.
Human Fetal Tissue. Human fetal tissue was obtained with full ethical approval
and consent from the Centre for Reproductive Biology, University of Edinburgh.
Antibodies. The following mAbs were used for immunofluorescence and flow
cytometry: MTS20 (IgM) (8) and MTS24 (IgG2a) (5) are rat mAbs that recognize
plasma membrane determinants and were a kind gift from R. L. Boyd (Monash
University Medical School, Melbourne, Australia); anti-cytokeratin (rabbit poly-
clonal anti-keratin, Dako); -CD45 (30-F11; FITC-conjugated); -CD11b (M1/70;
FITC-conjugated); -CD31 (MEC13.3, R-PE conjugated); -PDGFR (APA5); and
Ter119 (all BD PharMingen). 1D4 is a rat IgG raised against Plet-1, as described
herein. -Cldn4 and -Cldn7 (Zymed) are polyclonal sera that recognize intracel-
lular determinants; -Cldn4 was a kind gift from M. Furuse and S. Tsukita (Kyoto
University, Kyoto, Japan). Appropriate isotype-control antibodies (BD PharMin-
gen) provided negative controls in all experiments. Unconjugated mAbs were
detected by using mouse anti-rat IgM-PE (BD PharMingen), donkey anti-mouse
IgG F(ab)2-FITC, goat anti-rat IgM-Cy3, donkey anti-rat IgG-Cy3, goat anti-rat
IgG/M-FITC, and goat anti-rabbit IgG-FITC (all Jackson Laboratories), or goat
anti-rabbit IgG-Alexa647 (Invitrogen). TO-PRO3 (Molecular Probes) or DAPI was
used as a nuclear counterstain.
Flow Cytometry. Cells were dissociated to single cell suspensions and stained as
described (6). Cells were analyzed on a FACSCalibur (Becton Dickinson) and by
usingFlowJoVer.4.4.4 (TreeStar).TO-PRO3(MolecularProbes)or7AADwasused
to identify dead cells.
Purification of Fetal and Postnatal MTS20 Cells. Mouse fetal thymi were
microdissected, dissociated, and processed for flow cytometry as described (6).
MTS20CD45Ter119 and MTS20CD45Ter119 or MTS20CD31CD45
Ter119PDGFR and MTS20CD31CD45Ter119PDGFR populations were
isolated from fetal thymi by flow cytometric sorting, to a purity of95% for each
sample. To isolate postnatal MTS20and MTS20TEC, thymi were dissected from
2-mo-old mice and digested by using 0.125% (wt/vol) collagenase D at 37°C for 15
min (6). An initial enrichment for epithelial cells was achieved by using a Percoll
gradient. Cells collected from the gradient were immunostained by using MTS20
(PE) and the MTS20 and MTS20 fractions within the epithelial gate isolated
by flow cytometric cell sorting. These fractions were then stained with -CD45
and -CD11b (FITC-conjugated) and the MTS20CD45CD11b and
MTS20CD45CD11b fractions purified by a second sort, routinely to 95%
purity; cytospin analysis of sorted cells indicated that95% of MTS20 cells were
epithelial, based on anti-pancytokeratin staining. Flow cytometric sorting was
performed by using a MoFlo (DakoCytomation).
RNA Collection. Intact total RNA was extracted from individual samples by using
TRIZOL reagent (Invitrogen) or Qiazol reagent (Qiagen), according to the man-
ufacturer’s instructions, and the quality of the RNA determined by analysis on an
Agilent Bioanalyser (Agilent Technologies). For global expression profiling, RNA
samples were then pooled such that each pool contained RNA from 1  106
cells, DNase treated (DNA-free, Ambion), precipitated to the required concen-
tration,andprocessedforAffymetrixanalysis. ForqRT-PCRanalysis, sampleswere
used individually or pooled as required.
Affymetrix Microarray Analysis. Samples were labeled and hybridized to MOE-
430A and -B GeneChip arrays according to standard Affymetrix protocols. The
candidate list was obtained by analysis of arrays hybridized with cRNA from E15.5
MTS20CD45Ter119 TEPC and MTS20CD45Ter119 epithelium-enriched
stromal cells. Data were analyzed by using GENESPRING GX (Agilent) and Limma
(Bioconductor) software.
RT-PCR and Real-Time RT-PCR (qRT-PCR). Total RNA was isolated from microdis-
sected fetal thymus tissue or sorted cell populations as described, and single
stranded cDNA was synthesized by using SuperScript II reverse-transcriptase
Fig. 6. Expression of Plet-1 protein in
selected postnatal tissues. Immunohisto-
chemical staining of postnatal tissue with
MTS24,-CD49f,-pancytokeratin (panK),
-Cldn4, as indicated. (A) Postnatal mam-
mary gland; MTS24 stains ductal epithelial
cells but is not restricted to the CD49fbright
fraction that contains stem cells (24). Im-
ages show staining in a representative
duct. (B) Kidney; MTS24 colocalizes with
Cldn4 in the medullary collecting ducts
(27). Right (merge) shows high-power im-
age of sections in LeftandCenter. (C) Small
intestine; MTS24 specifically identifies
Peyers and Crypto Patches (arrows). Left
and Center indicate representative structures; Right shows colocalization of MTS24 with CD45 in the small intestine. (D) Pancreas; MTS24 stains ductal epithelial
cells, as evidenced by colocalization with -pancytokeratin. Nuclear stain where shown is 7AAD. All images are representative of at least three separate
experiments.
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(Invitrogen) and random hexamers or oligo(dT) primers according to the manu-
facturer’s instructions. RT-PCR was performed by using the primer pairs shown in
SI Table 3. For qRT-PCR analysis, gene-specific amplification was performed by
using (i) the iCycler iQ real-time PCR Detection system (Bio-Rad), using IQ SYBR
green Supermix (Bio-Rad) for quantification (Table 1): reactions were run for 40
cycles of 15 sec at 95°C and 60 sec at 60°C, after an initial 8.5 min at 95°C. A
dissociation thermal protocol was used to analyze the melting peaks of the
products. Relative expression level of the target gene was normalized to the
geometric mean of three internal control genes (Hprt, Ywhaz, and Hmbs). Du-
plicate samples on each plate and technical duplicates were run for each sample.
No RT and no template controls were included in all experiments; or (ii) a
LightCycler 480 (Roche) using the Roche Universal probe library and the Light-
Cycler 480 Probes Master (Roche) mastermix (Fig. 3). Specific amplification of
Plet-1 and HPRT was detected by using probes 20 and 95, respectively. Primer
sequences are shown in SI Table 4.
Cloning. For cloning of mousePlet-1and mouseCldn7, RT-PCR was carried out on
cDNA generated from E13.5 mouse thymus RNA, with primers specific for full
length mouse Plet-1 or Cldn7. PCR products were subcloned by using the T/A
TOPO PCR cloning kit (Invitrogen), sequenced by using BigDye Terminator reac-
tion mix (ABI), and sequences analyzed by using DNAStar software (Ver. 6). The
following primers were used: Plet-1F GTCGACATGCTGTCGCTCCGCTCC; Plet-1R
GCGGCCGCTTAGAAGAGGAGTTTACT; Cldn7F GTCGACATGGCCAACTCGGGC-
CTG; and Cldn7R GCGGCCGCTCACACGTATTCCTTGGA.
Cell Line Generation. The full length sequences encoding Cldn7 or Plet-1 were
subcloned into pPyCAGIP (32) and transfected into COS-7 or CHO cells by using
the standard Lipofectamine 2000 (Invitrogen) protocol; vehicle-only controls
were provided by parallel transfection with the eGFP expression plasmid, pPy-
CAGGFPIP (32), which was used to estimate transfection efficiency. Transient
expression of the respective genes was tested after 60 h by immunostaining and
flow cytometry. To generate stably transfected lines expressing GFP, Cldn7 or
Plet-1, the cells were placed in selective medium (GMEM containing 2 g/ml
Puromycin) 24–72 h after transfection, and medium was then renewed every
24–48 h. Ten days after transfection, Puromycin-resistant colonies were picked
and expanded in selective medium, and expression of the relevant protein
confirmed by flow cytometric analysis.
Immunohistochemistry. Eight-micrometer sections were cut and either stained
with hematoxylin/eosin or processed for immunohistochemistry, as described (9).
Isotype controls (not shown) were included in all experiments. Staining was
analyzed by using a Leica AOBS confocal microscope (Leica). The images pre-
sented are either single optical sections or projected focus stacks of serial optical
sections.
Western Blotting. Membrane preparations were obtained from E12.5 mouse
fetal thymicprimordia,asdescribed(7).Proteinswereseparatedbyelectrophore-
sis on a SDS/PAGE gel and blotted onto a PVDF membrane according to standard
protocols.
ISH.Whole-mount ISHwereperformedasdescribed (33)byusingprobesdirected
to full length or the 3 UTR of Plet-1 (‘‘mouse’’ in SI Fig. 10). BM-purple (Roche/
BMB) was used to localize the hybridized probe.
Generation of mAbs. Wistar rats were immunized with 1 107 COS-7 cells stably
transfectedwithPlet-1.Rats received intraperitoneal injectionsofcellsemulsified
in Complete Freund’s Adjuvant (Difco), followed by a boost in Incomplete
Freund’s adjuvant 22 days later. Rats were bled 13 days postboost and sera
assayed by immunofluorescence (IFA). The best responder was boosted with 1
107 cells in PBS 4 days before fusion. Spleen cells were fused with Sp2/O myeloma
cells according to standard procedures (34). Antibody-containing supernatants
were screened by IFA on transfected and nontransfected cells. Hybridomas pro-
ducing antibodies which reacted specifically with transfected cells were selected
for further study.
Note added in proof. We have recently become aware that the Plet-1 expression
pattern from E7.5 to E10.5 has been reported, using GenBank accession no.
NM029639ratherthan1600029D21Rik(35).Thefindingsreportedareconsistent
with those herein, although our interpretation of the Plet-1 E7.5 expression
pattern differs from that of Moore-Scott et al. (35).
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